RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+18.38%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$8.67B
AUM Growth
+$8.67B
(+15%)
Cap. Flow
+$213M
Cap. Flow
% of AUM
2.46%
Top 10 Holdings %
Top 10 Hldgs %
55.18%
Holding
87
New
9
Increased
9
Reduced
14
Closed
6
Top Buys
| 1 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$177M |
| 2 |
ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
|
$152M |
| 3 |
Vaxcyte
PCVX
|
$55.5M |
| 4 |
BIOA
BioAge Labs, Inc. Common Stock
BIOA
|
$46M |
| 5 |
IDEAYA Biosciences
IDYA
|
$42.7M |
Top Sells
| 1 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$88.9M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$75.5M |
| 3 |
Geron
GERN
|
$63.2M |
| 4 |
Ascendis Pharma
ASND
|
$59.4M |
| 5 |
UroGen Pharma
URGN
|
$51.7M |
Sector Composition
| 1 | Healthcare | 99.89% |
| 2 | Financials | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alto Neuroscience
ANRO
$97.7M
| $23.7M | 0.27% |
2,075,154
-10,400
| -0.5% | -$119K |
|
52
Sera Prognostics
SERA
$129M
| $23.7M | 0.27% |
3,032,808
| – | – |
|
53
Taysha Gene Therapies
TSHA
$791M
| $21.9M | 0.25% |
10,872,503
| – | – |
|
54
Immatics
IMTX
$662M
| $20M | 0.23% |
1,750,000
| – | – |
|
|
JBIO
55
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $19.2M | 0.22% |
262,631
| – | – |
|
56
Nuvalent
NUVL
$5.74B
| $18M | 0.21% |
176,281
+56,492
| +47% | +$5.78M |
|
|
THRD
57
DELISTED
Third Harmonic Bio
THRD
| $17.4M | 0.2% |
1,280,826
-752,230
| -37% | -$10.2M |
|
58
Vor Biopharma
VOR
$253M
| $15.9M | 0.18% |
22,748,880
| – | – |
|
59
Insmed
INSM
$30.3B
| $14.6M | 0.17% |
200,000
| – | – |
|
60
Pliant Therapeutics
PLRX
$105M
| $14.4M | 0.17% |
1,281,000
| – | – |
|
61
Tenaya Therapeutics
TNYA
$192M
| $13.5M | 0.16% |
6,982,587
-639,760
| -8% | -$1.23M |
|
62
Zura Bio
ZURA
$132M
| $13.1M | 0.15% |
3,217,503
| – | – |
|
63
Werewolf Therapeutics
HOWL
$62.6M
| $13M | 0.15% |
6,144,881
| – | – |
|
64
CervoMed
CRVO
$93M
| $11.9M | 0.14% |
817,120
| – | – |
|
65
Xencor
XNCR
$594M
| $11.6M | 0.13% |
+575,000
| New | +$11.6M |
|
66
Adicet Bio
ACET
$60.8M
| $10.9M | 0.13% |
7,541,000
| – | – |
|
67
Arvinas
ARVN
$580M
| $10.4M | 0.12% |
421,348
| – | – |
|
68
Avalo Therapeutics
AVTX
$139M
| $9.19M | 0.11% |
+967,000
| New | +$9.19M |
|
|
CMRX
69
DELISTED
Chimerix, Inc.
CMRX
| $8.18M | 0.09% |
8,800,000
| – | – |
|
|
BOLD
70
Boundless Bio
BOLD
$25.7M
| $7.57M | 0.09% |
2,180,631
| – | – |
|
71
Cidara Therapeutics
CDTX
$1.61B
| $7.56M | 0.09% |
+703,080
| New | +$7.56M |
|
|
PCSC
72
Perceptive Capital Solutions Corp Class A Ordinary Shares
PCSC
$117M
| $7.52M | 0.09% |
750,000
| – | – |
|
73
Lexeo Therapeutics
LXEO
$266M
| $4.94M | 0.06% |
546,554
-126,158
| -19% | -$1.14M |
|
74
Protara Therapeutics
TARA
$125M
| $3.48M | 0.04% |
1,900,000
| – | – |
|
|
ADGM
75
Adagio Medical Holdings, Inc Common Stock
ADGM
$25.1M
| $3.44M | 0.04% |
+1,333,926
| New | +$3.44M |
|